Kaptiron® is indicated for the treatment of chronic iron overload secondary to frequent blood transfusions, in patients 6 years of age and older with beta-thalassemia major, it is also indicated for the treatment of secondary chronic iron overload. to blood transfusions when treatment with deferoxamine is contraindicated or unsuitable. As indicated on the instructions
DCI | DEFERASIROX |
---|---|
Dosage | 125 mg |
Trade name | KAPTIRON® |
Name of the originator | EXJADE ® |
Presentation | 30 tablets |
Specialty | Chélateur de fer |